London School of Hygiene & Tropical Medicine , London , UK.
Independent Consultant , Bamako, Mali.
Glob Health Sci Pract. 2014 Jan 15;2(1):117-29. doi: 10.9745/GHSP-D-13-00130. eCollection 2014 Feb.
To evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass campaigns on the routine immunization program and the wider health system.
We used a mixed-methods case-study design, combining semi-structured interviews with 31 key informants, a survey among 18 health facilities, and analysis of routine health facility data on number of routine vaccinations and antenatal consultations before, during, and after the MenA vaccine campaign in December 2010. Survey and interview data were collected at the national level and in 2 regions in July and August 2011, with additional interviews in January 2012.
Many health system functions were not affected-either positively or negatively-by the MenA vaccine introduction. The majority of effects were felt on the immunization program. Benefits included strengthened communication and social mobilization, surveillance, and provider skills. Drawbacks included the interruption of routine vaccination services in the majority of health facilities surveyed (67%). The average daily number of children receiving routine vaccinations was 79% to 87% lower during the 10-day campaign period than during other periods of the month. Antenatal care consultations were also reduced during the campaign period by 10% to 15%. Key informants argued that, with an average of 14 campaigns per year, mass campaigns would have a substantial cumulative negative effect on routine health services. Many also argued that the MenA campaign missed potential opportunities for health systems strengthening because integration with other health services was lacking.
The MenA vaccine introduction interrupted routine vaccination and other health services. When introducing a new vaccine through a campaign, coverage of routine health services should be monitored alongside campaign vaccine coverage to highlight where and how long services are disrupted and to mitigate risks to routine services.
通过大规模疫苗接种活动评估脑膜炎球菌 A 型(MenA)疫苗在马里引入对常规免疫规划和更广泛卫生系统的影响。
我们采用混合方法病例研究设计,对 31 名关键信息提供者进行半结构式访谈,对 18 个卫生机构进行调查,并对 2010 年 12 月脑膜炎球菌 A 型疫苗接种活动前后常规卫生机构关于常规疫苗接种数量和产前咨询的数据进行分析。调查和访谈数据于 2011 年 7 月至 8 月在国家一级和 2 个地区收集,并于 2012 年 1 月进行了额外访谈。
许多卫生系统功能没有受到脑膜炎球菌 A 型疫苗引入的影响(无论是积极的还是消极的)。免疫规划受到的影响最大。受益包括加强了沟通和社会动员、监测和提供者技能。缺点包括在接受调查的大多数卫生机构(67%)中断了常规疫苗接种服务。在为期 10 天的疫苗接种活动期间,每天接受常规疫苗接种的儿童数量平均减少了 79%至 87%,比该月的其他时期要低。在活动期间,产前保健咨询也减少了 10%至 15%。关键信息提供者认为,由于每年平均有 14 次活动,大规模活动将对常规卫生服务产生重大的累积负面影响。许多人还认为,脑膜炎球菌 A 型疫苗接种活动错过了加强卫生系统的潜在机会,因为缺乏与其他卫生服务的整合。
脑膜炎球菌 A 型疫苗接种活动中断了常规疫苗接种和其他卫生服务。在通过活动引入新疫苗时,应监测常规卫生服务的覆盖率,以监测服务中断的地点和时间,并减轻对常规服务的风险。